Babies whose mothers were vaccinated against respiratory syncytial virus earlier in pregnancy had stronger protection against ...

We all know the risks of influenza and COVID for older people. But a third virus, RSV, can also land you in hospital. A free ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...

Cases of a specific respiratory virus are spiking in several states across the U.S. right now. In California, concentrations of HMPV were high in San Francisco, Sacramento, Napa and several other ...

TRIAL ON 55 CHARGES TIED TO THE SHOOTING. WELL, IT’S BEEN A ROUGH COLD AND FLU SEASON, AND A LESSER KNOWN VIRUS IS NOW HITTING SCHOOLS AND OFFICES QUITE HARD. IT’S CALLED METAPNEUMOVIRUS OR HMPV, AND ...

You may be sick with what feels like a nasty cold or a case of the flu, but there’s another, lesser-known respiratory virus that could be to blame. Cases of human metapneumovirus, known as HMPV, are ...

Every winter, like clockwork, respiratory viruses spread across the country: respiratory syncytial virus, commonly known as RSV, peaks first, between November and December, followed shortly thereafter ...

Please provide your email address to receive an email when new articles are posted on . Adults aged 75 years or older should receive a protein subunit respiratory syncytial virus vaccine. Adults aged ...

Merck & Co. (NYSE: MRK) on Thursday shared positive second RSV season findings from the Phase 3 SMART trial. The results from the SMART trial were presented at the RSVVW Conference and will be shared ...